INVO Fertility (IVF) Assets Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 61.98% |
| Jun 30, 2025 | 52.98% |
| Mar 31, 2025 | 101.40% |
| Dec 31, 2024 | 91.67% |
| Sep 30, 2024 | 33.90% |
| Jun 30, 2024 | -57.55% |
| Mar 31, 2024 | -57.38% |
| Dec 31, 2023 | 88.51% |
| Sep 30, 2023 | 79.28% |
| Jun 30, 2023 | 33.74% |
| Mar 31, 2023 | -26.35% |
| Dec 31, 2022 | 69.34% |
| Sep 30, 2022 | 84.33% |
| Jun 30, 2022 | 101.19% |
| Mar 31, 2022 | 110.65% |
| Dec 31, 2021 | 103.52% |
| Sep 30, 2021 | 81.95% |
| Jun 30, 2021 | 83.78% |
| Mar 31, 2021 | 79.34% |
| Dec 31, 2020 | 79.97% |
| Sep 30, 2020 | 53.35% |
| Jun 30, 2020 | 69.50% |
| Mar 31, 2020 | 53.14% |
| Dec 31, 2019 | 75.43% |
| Sep 30, 2019 | 90.75% |
| Jun 30, 2019 | 100.13% |
| Mar 31, 2019 | 98.10% |
| Dec 31, 2018 | 44.70% |
| Sep 30, 2018 | 51.58% |
| Jun 30, 2018 | 58.26% |
| Mar 31, 2018 | 21.42% |
| Dec 31, 2017 | 16.29% |
| Sep 30, 2017 | 7.40% |
| Jun 30, 2017 | 3.88% |
| Mar 31, 2017 | 8.71% |
| Dec 31, 2016 | 17.49% |
| Sep 30, 2016 | 23.68% |
| Jun 30, 2016 | 24.45% |
| Dec 31, 2015 | 26.22% |